stars 1 stars 2 stars 3

Azyro is developing Bioelectronic Medical Devices designed to revolutionize wound care and infection control. The system is modular and scalable, making it adaptable for both hospital and home-care applications. It is designed to be safe and easy to use, integrating seamlessly into existing treatment pathways and IT environments without disrupting established workflows. The technology is designed to reduce wound healing time, lower microbial burden, and alleviate pain. By potentially accelerating recovery and helping to prevent amputations, it could also contribute to reducing overall healthcare costs. A key technological advantage is its intended non-invasive and non-contact application, which may allow therapeutic effects to penetrate deeper tissue layers more effectively. Traditional treatments such as antibiotics, wound dressings, and cold plasma therapies face significant limitations, particularly in addressing resistant bacteria and deep tissue wounds (wound pockets). Building on very successful pre-clinical tests, Azyro’s innovative magnetic field therapy is designed to address these challenges, offering a solution that is more effective, scalable, and safer than current alternatives.

Employees 8 (5 on RocketReach)
Founded 2021
Industry Medical Devices

Azyro SA Questions

Jerry Wagner is the Marketing Communications Director of Azyro SA.

5 people are employed at Azyro SA.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users